Cerus Corporation

CERS

Healthcare diagnostics

$2.70vs prev close▼-0.11(-3.91%)

$1.1752W Range$3.47

67% from low

-0.16 (-5.46%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

6 buys

Consecutive buys

1M net buy

+$2.9M

≈ +1.0M shares

Portfolio Weight

0.28%

1M -0.10%p

Holding ETFs

2 ETFs

ARKG · ARKK

Sell · Weight Down

ARK net-sold the stock and the price fell, decreasing its portfolio weight.

Shares -2.8% · Market value -32.7% · Weight -0.10%p

Trade Intensity

Consecutive buys 6

Basis: 0 sells · 6 buys in 1M · Multi-ETF simultaneous buy · weight -0.10%p decrease

Trade Log6-day BUY streak

Date	Action	ETF	Shares	Close	Est. total
26.08.17	BUY	ARKG · ARKK	451,278	$2.97	$1.3M
26.08.14	BUY	ARKG · ARKK	86,875	$2.98	$258.9K
26.08.13	BUY	ARKG · ARKK	69,667	$2.84	$197.9K
26.08.12	BUY	ARKG · ARKK	93,956	$2.71	$254.6K
26.08.11	BUY	ARKG · ARKK	255,751	$2.57	$656.0K
26.08.10	BUY	ARKG · ARKK	87,357	$2.52	$220.1K
26.06.12	SELL	ARKK	4,656	$2.56	$11.9K
26.06.11	SELL	ARKK	540,764	$2.59	$1.4M
26.06.10	SELL	ARKK	152,004	$2.56	$389.1K
26.03.06	BUY	ARKG	84,004	$1.93	$162.1K
26.03.05	BUY	ARKG · ARKK	612,501	$2.04	$1.2M
26.03.04	BUY	ARKG · ARKK	130,033	$2.24	$291.3K
26.03.03	BUY	ARKG · ARKK	498,203	$2.13	$1.1M
24.10.31	BUY	ARKG · ARKK	407,514	$1.57	$639.8K
24.10.30	BUY	ARKG · ARKK	916,856	$1.72	$1.6M

08.17BUY

451,278

ARKG · ARKKClose$2.97Est. total$1.3M

08.14BUY

86,875

ARKG · ARKKClose$2.98Est. total$258.9K

08.13BUY

69,667

ARKG · ARKKClose$2.84Est. total$197.9K

08.12BUY

93,956

ARKG · ARKKClose$2.71Est. total$254.6K

08.11BUY

255,751

ARKG · ARKKClose$2.57Est. total$656.0K

08.10BUY

87,357

ARKG · ARKKClose$2.52Est. total$220.1K

06.12SELL

4,656

ARKKClose$2.56Est. total$11.9K

06.11SELL

540,764

ARKKClose$2.59Est. total$1.4M

06.10SELL

152,004

ARKKClose$2.56Est. total$389.1K

03.06BUY

84,004

ARKGClose$1.93Est. total$162.1K

03.05BUY

612,501

ARKG · ARKKClose$2.04Est. total$1.2M

03.04BUY

130,033

ARKG · ARKKClose$2.24Est. total$291.3K

03.03BUY

498,203

ARKG · ARKKClose$2.13Est. total$1.1M

10.31BUY

407,514

ARKG · ARKKClose$1.57Est. total$639.8K

10.30BUY

916,856

ARKG · ARKKClose$1.72Est. total$1.6M

1 / 5

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

15,479,196

Portfolio Weight

0.28%

in ETF 0.99%

Est. Value

$35M

30D Net

+$3M

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Strong Buy

Buy

Analyst Targets

avg.

$4.67

vs Current ▲ +66.1% upside

Current$2.81

Low ~ High$4.00 ~ $5.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Freedom Broker

Buy

$6.50

+131.32%

—

Upgrade

2026-08-20

BTIG

Buy

$4.00

+42.35%

—

Upgrade

2026-05-01

Cantor Fitzgerald

Overweight

$4.00

+42.35%

—

Maintain

2025-02-21

Stifel

Buy

$3.00

+6.76%

—

Maintain

2024-10-17

Cantor Fitzgerald

Overweight

$4.00

+42.35%

—

Maintain

2024-05-03

1 / 4

Avg Target

$4.67

vs Current ▲ +66.1% upside

Strong Buy

3 analysts

Buy 3

Low $4.00

Current $2.81

High $5.00

Firm	Position	Target	Upside	Close	Action	Date
Freedom Broker	Buy	$6.50	+131.32%	—	Upgrade	26.08.20
BTIG	Buy	$4.00	+42.35%	—	Upgrade	26.05.01
Cantor Fitzgerald	Overweight	$4.00	+42.35%	—	Maintain	25.02.21
Stifel	Buy	$3.00	+6.76%	—	Maintain	24.10.17
Cantor Fitzgerald	Overweight	$4.00	+42.35%	—	Maintain	24.05.03

1 / 4

Price Information

Previous Close$2.79

Open$2.81

Day Range$2.78 - $2.87

52-Week Range$1.17 - $3.47

1-Year Change119.53%

Trading Volume

Volume2,489,755

Avg Volume (3mo)2,756,262

Valuation

Market Cap566.3M

Book Value$0.35

Shares Outstanding201,524,898

Financials

Revenue (TTM)221.6M

Net Income-6,783,000

EPS$-0.03

EBITDA66.0K

Profitability

P/E Ratio-

P/B Ratio8.07

Return on Equity (ROE)-10.77%

Return on Assets (ROA)-0.48%

Profit Margin-3.06%

EV/EBITDA8901.68

Beta1.77

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)77.05

Company Overview

Cerus Corporation is a biomedical products company focused on enhancing blood safety through its proprietary INTERCEPT Blood System technology. This system is designed to reduce blood-borne pathogens in donated blood components, including platelets, plasma, and red blood cells, for transfusion. Cerus markets its INTERCEPT systems globally through direct sales and distributors, positioning itself as a leader in pathogen reduction for blood products.

P/B

8.07

High valuation

ROE

-10.8%

Net loss

Beta

1.77

High volatility

RSI(14)

77.0

Overbought

AI-generated summary. Not investment advice.

Cerus Corporation

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks